Evidence map›Paper›PMID 29561866›Full record

Trial reportPloS one2018

Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial.

Fleur P Paling, Karina Olsen, Kristin Ohneberg, Martin Wolkewitz, Vance G Fowler, Mark J DiNubile, Hasan S Jafri, Frangiscos Sifakis, Marc J M Bonten, Stephan J Harbarth and 1 more

Open access · goldAbstract readClinical Trial, Phase IIClinical Trial, Phase IIIRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Methicillin-resistantCurrent pharmaceutical biotechnology · 2025
    Review
  3. Article
  4. Effects of preoperativeJournal of thoracic disease · 2022
    Article
  5. Review
  6. Review
  7. Classifying Infection Risk Following Pediatric Cardiac Surgery.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Fleur P PalingJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.ORCID 0000-0002-5713-7652
Karina OlsenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.
Kristin OhnebergInstitute for Medical Biometry and Statistics, University Medical Center Freiburg, Freiburg, Germany.
Martin WolkewitzInstitute for Medical Biometry and Statistics, University Medical Center Freiburg, Freiburg, Germany.
Vance G FowlerDivision of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, United States of America.
Mark J DiNubileMerck & Company Incorporation, Kenilworth, New Jersey, United States of America.
Hasan S JafriMedImmune, Gaithersburg, Maryland, United States of America.
Frangiscos SifakisAstraZeneca Pharmaceuticals LP, Gaithersburg, Maryland, United States of America.
Marc J M BontenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.
Stephan J HarbarthGeneva University Hospitals and Medical School, Geneva, Switzerland.
Jan A J W KluytmansJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.
University Medical Center Utrecht · NLUniversity Medical Center Freiburg · DEAstraZeneca (United States) · USDuke Medical Center · USMerck & Co., Inc., Rahway, NJ, USA (United States) · USUniversity Hospital of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIdentifying patients undergoing cardiothoracic surgery at high risk of Staphylococcus aureus surgical site infection (SSI) is a prerequisite for implementing effective preventive interventions. The objective of this study was to develop a risk prediction model for S. aureus SSI or bacteremia after cardiothoracic surgery based on pre-operative variables. MATERIALS/

methodsData from the Merck Phase IIb/III S. aureus vaccine (V710-P003) clinical trial were analyzed. In this randomized placebo-controlled trial, the effect of preoperative vaccination against S. aureus was investigated in patients undergoing cardiothoracic surgery. The primary outcome was deep/superficial S. aureus SSI or S. aureus bacteremia through day 90 after surgery. Performance, calibration, and discrimination of the final model were assessed.

resultsOverall 164 out of 7,647 included patients (2.1%) developed S. aureus infection (149 SSI, 15 bacteremia, 28 both). Independent risk factors for developing the primary outcome were pre-operative colonization with S. aureus (OR 3.08, 95% confidence interval [CI] 2.23-4.22), diabetes mellitus (OR 1.87, 95% CI 1.34-2.60), BMI (OR 1.02 per kg/m2, 95% CI 0.99-1.05), and CABG (OR 2.67, 95% CI 1.91-3.78). Although vaccination had a significant (albeit modest) protective effect, it was omitted from the model because its addition did not significantly change the coefficients of the final model and V710-vaccine development has been discontinued due to insufficient efficacy. The final prediction model had moderate discriminative accuracy (AUC-value, 0.72).

conclusionPre-operative S. aureus colonization status, diabetes mellitus, BMI, and type of surgical procedure moderately predicted the risk of S. aureus SSI and/or bacteremia among patients undergoing cardiothoracic surgery.

Indexed as

AdultAgedCardiovascular Surgical ProceduresDouble-Blind MethodFemaleHumansMaleMiddle AgedProspective StudiesRisk FactorsStaphylococcal InfectionsStaphylococcal VaccinesStaphylococcus aureusSurgical Wound InfectionVaccinationStaphylococcal VaccinesV710 vaccine

Identifiers

PMID29561866
PMCPMC5862433
OpenAlexW2790299333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.